Free Trial
NYSEAMERICAN:XTNT

Xtant Medical (XTNT) Stock Price, News & Analysis

Xtant Medical logo
$0.64 +0.01 (+1.43%)
Closing price 08/29/2025 04:10 PM Eastern
Extended Trading
$0.63 -0.01 (-1.41%)
As of 08/29/2025 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Xtant Medical Stock (NYSEAMERICAN:XTNT)

Key Stats

Today's Range
$0.61
$0.64
50-Day Range
$0.55
$0.74
52-Week Range
$0.33
$0.78
Volume
33,262 shs
Average Volume
75,297 shs
Market Capitalization
$83.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
Consensus Rating
Buy

Company Overview

Xtant Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

XTNT MarketRank™: 

Xtant Medical scored higher than 47% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Xtant Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Xtant Medical has received no research coverage in the past 90 days.

  • Read more about Xtant Medical's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Xtant Medical is -15.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Xtant Medical is -15.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Xtant Medical has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Xtant Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.02% of the float of Xtant Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Xtant Medical has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Xtant Medical has recently increased by 34.35%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Xtant Medical does not currently pay a dividend.

  • Dividend Growth

    Xtant Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.02% of the float of Xtant Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Xtant Medical has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Xtant Medical has recently increased by 34.35%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Xtant Medical has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.09 average news sentiment score of Medical companies.
  • Search Interest

    1 people have searched for XTNT on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Xtant Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Xtant Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.70% of the stock of Xtant Medical is held by insiders.

  • Percentage Held by Institutions

    69.33% of the stock of Xtant Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Xtant Medical's insider trading history.
Receive XTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XTNT Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
Earnings Preview For Xtant Medical Hldgs
See More Headlines

XTNT Stock Analysis - Frequently Asked Questions

Xtant Medical's stock was trading at $0.4681 on January 1st, 2025. Since then, XTNT stock has increased by 36.5% and is now trading at $0.6390.

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) announced its quarterly earnings data on Tuesday, November, 12th. The medical device company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.02. The medical device company had revenue of $27.94 million for the quarter. Xtant Medical had a negative trailing twelve-month return on equity of 10.12% and a negative net margin of 3.59%.
Read the conference call transcript
.

Xtant Medical's stock reverse split on Wednesday, February 14th 2018.The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Top institutional investors of Xtant Medical include Nantahala Capital Management LLC (49.09%), AWM Investment Company Inc. (5.06%), Crescent Grove Advisors LLC (0.30%) and Bridgeway Capital Management LLC (0.13%). Insiders that own company stock include Stavros G Vizirgianakis, Sean E Browne and Scott C Neils.
View institutional ownership trends
.

Shares of XTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Xtant Medical investors own include Meta Platforms (META), Aurinia Pharmaceuticals (AUPH), NVIDIA (NVDA), Alibaba Group (BABA), Tesla (TSLA) and Broadcom (AVGO).

Company Calendar

Last Earnings
11/12/2024
Today
8/31/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:XTNT
Previous Symbol
AMEX:XTNT
CIK
1453593
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$1.50
Low Price Target
$1.50
Potential Upside/Downside
+134.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.45 million
Net Margins
-3.59%
Pretax Margin
-3.34%
Return on Equity
-10.12%
Return on Assets
-4.67%

Debt

Debt-to-Equity Ratio
0.46
Current Ratio
2.47
Quick Ratio
1.16

Sales & Book Value

Annual Sales
$117.27 million
Price / Sales
0.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.37 per share
Price / Book
1.73

Miscellaneous

Outstanding Shares
130,320,000
Free Float
117,675,000
Market Cap
$83.27 million
Optionable
Not Optionable
Beta
-0.21
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSEAMERICAN:XTNT) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners